SAN DIEGO, May 07, 2018 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its first quarter financial results and business update on Thursday, May 10, 2018 at 5:30 PM Eastern Time.
The dial-in information is as follows:
Dial-In Number: +1.877.402.3914
Conference ID: 7194327
Prior to the webcast at approximately 4:30 PM Eastern Time on May 10, Cytori will issue its first quarter earnings release which will review Cytori’s first quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.
About Cytori Therapeutics, Inc.
Cytori is a therapeutics company developing regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for a variety of medical conditions. Cytori Nanomedicine™ is developing encapsulated therapies for regenerative medicine and oncologic indications using technology that allows Cytori to use the benefits of its encapsulation platform to develop novel therapeutic strategies and reformulate other drugs to optimize their clinical properties. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information, visit www.cytori.com.
Cytori Therapeutics, Inc.
Tiago Girao, 1.858.458.0900
[email protected]


Meta Platforms Cuts Equity Awards Again Amid Massive AI Investment Push
Texas Attorney General Ken Paxton Sues Sanofi Over Alleged Healthcare Bribery Scheme
Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement
Amazon Surpasses Walmart in Annual Revenue, Signaling a New Era in Retail Competition
Airbus Cuts Jet Production Target Amid Pratt & Whitney Engine Shortages, Q4 Profit Jumps 17%
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies
Nvidia Nears $30 Billion Investment in OpenAI, Replacing Previous $100 Billion AI Partnership
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings
Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 



